CAS RN: 2565705-02-2

1,2-Benzenediamine, N1-[(S)-(3-chloro-2-pyridinyl)(2,2-difluoro-1,3-benzodioxol-4-yl)methyl]-N2-[4-methoxy-6-(1-piperazinyl)-1,3,5-triazin-2-yl]-4-(methylsulfonyl)-

Product Availability

Choose a grade to view its available package options.

5 package records3 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250217 100mg Out of stock Inquiry
Batchno.20260525 10mg In stock Shanghai Inquiry
Batchno.20250202 25mg In stock Shanghai Inquiry
Batchno.20260212 50mg In stock Shanghai Inquiry
Batchno.20250410 5mg / 25mg Out of stock 8-10 business days Inquiry
  • Product code: starshine_CAS2565705-02-2
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

2565705-02-2 / 1-N-[(S)-(3-chloro-2-pyridinyl)-(2,2-difluoro-1,3-benzodioxol-4-yl)methyl]-2-N-(4-methoxy-6-piperazin-1-yl-1,3,5-triazin-2-yl)-4-methylsulfonylbenzene-1,2-diamine

Standard CAS: 2565705-02-2 Multi CAS: No

Basic Information

CAS
2565705-02-2
Multi CAS
No
Molecular Formula
C28H27ClF2N8O5S
Molecular Weight
661.100000
Exact Mass
660.148171
SMILES
COC1=NC(=NC(=N1)N2CCNCC2)NC3=C(C=CC(=C3)S(=O)(=O)C)N[C@@H](C4=C5C(=CC=C4)OC(O5)(F)F)C6=C(C=CC=N6)Cl
InChI
InChI=1S/C28H27ClF2N8O5S/c1-42-27-37-25(36-26(38-27)39-13-11-32-12-14-39)35-20-15-16(45(2,40)41)8-9-19(20)34-22(23-18(29)6-4-10-33-23)17-5-3-7-21-24(17)44-28(30,31)43-21/h3-10,15,22,32,34H,11-14H2,1-2H3,(H,35,36,37,38)/t22-/m0/s1
InChIKey
QJIMSJUUARCROQ-QFIPXVFZSA-N

Computed Properties

Structural Parameters

Heavy atom count
45
Aromatic heavy atom count
24
Fraction Csp3
0.29
Rotatable bonds
9
H-bond acceptors
13
H-bond donors
3
Molar refractivity
161.65
TPSA
152.72

LogP / Solubility

WLOGP
4.01
MLOGP
3.58
XLogP3
4.5
Consensus LogP
4.03
Log S (ESOL)
-6.26
Class (ESOL)
Insoluble
Log S (Ali)
-7.87
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-8.36
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-3.91

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Leadlikeness
No
Synthetic Accessibility
6

Get In Touch

Contact Us